XML 57 R46.htm IDEA: XBRL DOCUMENT
v3.25.2

DISCONTINUED OPERATIONS - Additional Information (Details) - USD ($) |  | 3 Months Ended | 6 Months Ended | 21 Months Ended | 62 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Apr. 24, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Apr. 23, 2024 | Apr. 23, 2024 | Dec. 31, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Loss on disposal of discontinued operations |  |  | $ (1,799,000) | $ 0 | $ (1,799,000) |  |  |
Revenue from collaborative agreement |  | $ 0 | 302,000 | 0 | 1,275,000 |  |  |
Accounts receivable |  | 1,859,000 |  | 1,859,000 |  |  |  | $ 1,694,000
Total revenues | Rezafungin |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Liabilities related to discontinued operations |  | 0 |  | 0 |  |  |  | 0
Assets related to discontinued operations |  | 0 |  | 0 |  |  |  | 0
Cash provided by (used in) operating activities, discontinued operations |  |  |  |  | 17,600,000 |  |  |
Cash provided by (used in) financing activities, discontinued operations |  |  |  |  | 0 |  |  |
Cash provided by (used in) investing activities, discontinued operations |  |  |  |  | 0 |  |  |
Total revenues |  |  | 21,762,000 |  | 29,252,000 |  |  |
Loss on disposal of discontinued operations |  |  | (1,799,000) |  | (1,799,000) |  |  |
Total revenues | Rezafungin | Related Party | Collaborative Arrangement |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Revenue, remaining performance obligation, amount |  | 0 |  | 0 |  |  |  |
Accounts receivable |  | 0 |  | 0 |  |  |  | $ 0
Napp Pharmaceutical Group Limited | Total revenues | Rezafungin | Related Party | Collaborative Arrangement |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Collaborative agreement, maximum cost share, forgiveness amount | $ 11,100,000 |  |  |  |  |  |  |
Collaborative arrangement, carry over services agreement term (in days) | 45 days |  |  |  |  |  |  |
Collaborative arrangement, other services agreement term (in days) | 75 days |  |  |  |  |  |  |
Collaborative arrangement, transaction, value | $ 21,200,000 |  |  |  |  |  |  |
Contract liabilities, forgiveness amount | 25,300,000 |  |  |  |  |  |  |
Transition services | 600,000 |  |  |  |  |  |  |
Payments related to collaborative agreement | 2,100,000 |  |  |  |  |  |  |
Accounts receivable, forgiveness amount | 2,600,000 |  |  |  |  |  |  |
Total revenues |  |  | 100,000 |  |  |  |  |
Loss on disposal of discontinued operations | $ 300,000 |  |  |  |  |  |  |
Collaborative arrangement, transitions services term (in days) | 76 days |  |  |  |  |  |  |
Revenue, remaining performance obligation, amount |  | 0 |  | 0 |  |  |  |
Accounts receivable |  | $ 1,900,000 |  | $ 1,900,000 |  |  |  |
Napp Pharmaceutical Group Limited | Total revenues | Rezafungin | Related Party | Collaborative Arrangement | Rezafungin Assets, including Sale of Intellectual Property and Inventory |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Total revenues | $ 20,800,000 |  |  |  |  |  |  |
Melinta | Total revenues | Rezafungin | Related Party | Collaborative Arrangement |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Payments related to collaborative agreement |  |  |  |  |  | $ 30,000,000 |  |
Revenue from collaborative agreement |  |  | 189,000 |  | 582,000 |  |  |
Melinta | Total revenues | Rezafungin | Related Party | Collaborative Arrangement | Milestone Achievement |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Revenue from collaborative agreement |  |  |  |  |  | $ 20,000,000 |  |
Mundipharma | Total revenues | Rezafungin | Related Party | Collaborative Arrangement |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Payments related to collaborative agreement |  |  |  |  |  |  | $ 30,000,000 |
Collaborative agreement, maximum cost share |  |  |  |  |  |  | 31,200,000 |
Revenue from collaborative agreement |  |  | $ 21,573,000 |  | $ 28,670,000 |  |  |
Mundipharma | Total revenues | Rezafungin | Related Party | Collaborative Arrangement | Milestone Achievement |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |
Revenue from collaborative agreement |  |  |  |  |  |  | $ 27,900,000 |

X
- Definition Accounts Receivable, after Allowance for Credit Loss, Current, Forgiveness Amount + References No definition available. + Details
Name: | cdtx_AccountsReceivableAfterAllowanceForCreditLossCurrentForgivenessAmount
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Collaborative Arrangement, Carry Over Services Agreement Term + References No definition available. + Details
Name: | cdtx_CollaborativeArrangementCarryOverServicesAgreementTerm
Namespace Prefix: | cdtx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative Arrangement, Maximum Third Party Share Of Cost + References No definition available. + Details
Name: | cdtx_CollaborativeArrangementMaximumThirdPartyShareOfCost
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Collaborative Arrangement, Maximum Third Party Share Of Cost, Forgiveness Amount + References No definition available. + Details
Name: | cdtx_CollaborativeArrangementMaximumThirdPartyShareOfCostForgivenessAmount
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Collaborative Arrangement, Other Services Agreement Term + References No definition available. + Details
Name: | cdtx_CollaborativeArrangementOtherServicesAgreementTerm
Namespace Prefix: | cdtx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative Arrangement, Transaction, Value + References No definition available. + Details
Name: | cdtx_CollaborativeArrangementTransactionValue
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaborative Arrangement, Transitions Services Term + References No definition available. + Details
Name: | cdtx_CollaborativeArrangementTransitionsServicesTerm
Namespace Prefix: | cdtx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disposal Group, Including Discontinued Operation, Gain (Loss) On Disposal + References No definition available. + Details
Name: | cdtx_DisposalGroupIncludingDiscontinuedOperationGainLossOnDisposal
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments Related To Collaborative Agreements + References No definition available. + Details
Name: | cdtx_PaymentsRelatedToCollaborativeAgreements
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Revenue From Collaborative Arrangement, Excluding Revenue From Contract With Customer, Liability, Forgiveness Amount + References No definition available. + Details
Name: | cdtx_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomerLiabilityForgivenessAmount
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Revenue From Collaborative Arrangement, Excluding Revenue From Contract With Customer, Transition Services + References No definition available. + Details
Name: | cdtx_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomerTransitionServices
Namespace Prefix: | cdtx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2 + Details
Name: | us-gaap_AccountsReceivableNetCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount classified as assets attributable to disposal group held for sale or disposed of. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 10 -SubTopic 20 -Topic 205 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5B -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11 + Details
Name: | us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash inflow (outflow) from financing activity attributable to discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24 + Details
Name: | us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from investing activity attributable to discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5B -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B + Details
Name: | us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow (outflow) from operating activity attributable to discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5B -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B + Details
Name: | us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3A -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3A -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A + Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount classified as liabilities attributable to disposal group held for sale or disposed of. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 10 -SubTopic 20 -Topic 205 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483475/205-20-45-10 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5B -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11 + Details
Name: | us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 3 -SubTopic 10 -Topic 808 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479428/808-10-45-3 + Details
Name: | us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cdtx_RezafunginMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cdtx_NappPharmaceuticalGroupLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cdtx_RezafunginAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cdtx_MelintaTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=cdtx_MilestoneAchievementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cdtx_MundipharmaMedicalCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |